HARBOUR BIOMED

harbour-biomed-logo

Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.

#SimilarOrganizations #People #Financial #Event #Website #More

HARBOUR BIOMED

Social Links:

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2016-01-01

Address:
Shanghai, Shanghai, China

Country:
China

Website Url:
http://www.harbourbiomed.com

Total Employee:
51+

Status:
Active

Contact:
+86-21-51370990

Email Addresses:
[email protected]

Total Funding:
312.8 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Mobile Non Scaleable Content Nginx Euro Microsoft Azure DNS PHP


Similar Organizations

eidos-therapeutics-logo

Eidos Therapeutics

Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

i-mab-biopharma-logo

I-Mab Biopharma

I-Mab is a dynamic and fast-growing global biotech company exclusively focused on developing innovative biologics.

iaso-biotherapeutics-logo

IASO Biotherapeutics

IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

inventisbio-logo

InventisBio

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

lianchuang-biomedicine-logo

Lianchuang Biomedicine

Lianchuang Bio is a pharmaceutical company that offers R&D, production, and marketing of advanced pharmaceutical intermediates.

palisade-bio-logo

Palisade Bio

Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.

sirnaomics-logo

Sirnaomics

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.

tot-biopharm-logo

TOT BIOPHARM

TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.


Current Advisors List

robert-kamen_image

Robert Kamen Board Of Director @ Harbour Biomed
Board_member
2016-12-01

Current Employees Featured

jingsong-wang_image

Jingsong Wang
Jingsong Wang Founder & CEO @ Harbour Biomed
Founder & CEO
2016-12-01

frank-grosveld_image

Frank Grosveld
Frank Grosveld Founding Chief Scientific Officer @ Harbour Biomed
Founding Chief Scientific Officer

xiaoxiang-chen_image

Xiaoxiang Chen
Xiaoxiang Chen Chief Development Officer @ Harbour Biomed
Chief Development Officer
2018-12-01

weihao-xu_image

Weihao Xu
Weihao Xu Chief Strategy Officer @ Harbour Biomed
Chief Strategy Officer
2021-12-01

humphrey-gardner_image

Humphrey Gardner
Humphrey Gardner Chief Medical Officer @ Harbour Biomed
Chief Medical Officer
2022-04-01

mai-jing-liao_image

Mai-Jing Liao
Mai-Jing Liao Chief Business Officer @ Harbour Biomed
Chief Business Officer

not_available_image

Yingying Chen
Yingying Chen CFO @ Harbour Biomed
CFO
2021-07-01

Founder


frank-grosveld_image

Frank Grosveld

jeff-he_image

Jeff He

jingsong-wang_image

Jingsong Wang

liang-schweizer_image

Liang Schweizer

Stock Details


Company's stock symbol is HKG:2142

Acquisitions List

Date Company Article Price
2016-12-19 Harbour Antibodies Harbour Antibodies acquired by Harbour Biomed N/A

Investors List

hudson-bay-capital-management_image

Hudson Bay Capital Management

Hudson Bay Capital Management investment in Series C - Harbour Biomed

greater-bay-area-homeland-development-fund_image

Greater Bay Area Homeland Development Fund

Greater Bay Area Homeland Development Fund investment in Series C - Harbour Biomed

octagon-capital-partners_image

Octagon Capital Partners

Octagon Capital Partners investment in Series C - Harbour Biomed

country-garden_image

Country Garden

Country Garden investment in Series C - Harbour Biomed

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Harbour Biomed

shenzhen-gtja-investment-group_image

ShenZhen GTJA Investment Group

ShenZhen GTJA Investment Group investment in Series C - Harbour Biomed

sk-holdings_image

SK Holdings

SK Holdings investment in Series B - Harbour Biomed

zhejiang-university_image

Zhejiang University

Zhejiang University investment in Series B - Harbour Biomed

greater-bay-area-homeland-development-fund_image

Greater Bay Area Homeland Development Fund

Greater Bay Area Homeland Development Fund investment in Series B - Harbour Biomed

gic_image

GIC

GIC investment in Series B - Harbour Biomed

Official Site Inspections

http://www.harbourbiomed.com Semrush global rank: 3.95 M Semrush visits lastest month: 3.16 K

  • Host name: ec2-140-179-40-210.cn-north-1.compute.amazonaws.com.cn
  • IP address: 140.179.40.210
  • Location: Beijing China
  • Latitude: 39.9288
  • Longitude: 116.3889
  • Timezone: Asia/Shanghai

Loading ...

More informations about "Harbour Biomed" on Search Engine